FULLER H B CO·4

Nov 14, 2:13 PM ET

Weaver Nathan D. 4

4 · FULLER H B CO · Filed Nov 14, 2025

Insider Transaction Report

Form 4
Period: 2025-11-13
Weaver Nathan D.
Exec VP, Business Transform.
Transactions
  • Sale

    Common Stock

    2025-11-13$58.38/sh7,075$413,0189,441 total
  • Exercise/Conversion

    Common Stock

    2025-11-13$33.38/sh+9,546$318,64516,516 total
  • Exercise/Conversion

    Employee Stock Option (Right-to-Buy)

    2025-11-13$33.38/sh9,546$318,6450 total
    Exercise: $33.38From: 2017-01-19Exp: 2026-01-19Common Stock (9,546 underlying)
Holdings
  • Employee Stock Option (Right-to-Buy)

    Exercise: $45.05From: 2020-01-24Exp: 2029-01-24Common Stock (6,115 underlying)
    6,115
  • Employee Stock Option (Right-to-Buy)

    Exercise: $26.66From: 2021-04-02Exp: 2030-04-02Common Stock (9,732 underlying)
    9,732
  • Employee Stock Option (Right-to-Buy)

    Exercise: $48.35From: 2021-01-24Exp: 2030-01-24Common Stock (5,362 underlying)
    5,362
  • Employee Stock Option (Right-to-Buy)

    Exercise: $50.10From: 2018-01-26Exp: 2027-01-26Common Stock (4,976 underlying)
    4,976
  • Employee Stock Option (Right-to-Buy)

    Exercise: $51.89From: 2022-01-27Exp: 2031-01-27Common Stock (11,992 underlying)
    11,992
  • Employee Stock Option (Right-to-Buy)

    Exercise: $53.57From: 2019-01-25Exp: 2028-01-25Common Stock (4,585 underlying)
    4,585
  • Employee Stock Option (Right-to-Buy)

    Exercise: $64.28From: 2026-01-27Exp: 2035-01-27Common Stock (14,844 underlying)
    14,844
  • Employee Stock Option (Right-to-Buy)

    Exercise: $68.17From: 2024-01-24Exp: 2033-01-24Common Stock (9,634 underlying)
    9,634
  • Employee Stock Option (Right-to-Buy)

    Exercise: $72.94From: 2023-01-24Exp: 2032-01-24Common Stock (8,249 underlying)
    8,249
  • Employee Stock Option (Right-to-Buy)

    Exercise: $77.72From: 2025-01-26Exp: 2034-01-26Common Stock (9,806 underlying)
    9,806
  • Phantom Units

    Exercise: $0.00Common Stock (5,895.44 underlying)
    5,895.44
  • Restricted Stock Units

    Exercise: $0.00From: 2024-01-24Exp: 2026-01-24Common Stock (562.91 underlying)
    562.91
  • Restricted Stock Units

    Exercise: $0.00From: 2025-01-26Exp: 2027-01-26Common Stock (1,129.28 underlying)
    1,129.28
  • Restricted Stock Units

    Exercise: $0.00From: 2026-01-27Exp: 2028-01-27Common Stock (2,640.43 underlying)
    2,640.43
Footnotes (10)
  • [F1]The price reported is the weighted average sale price for the transaction reported. The prices received ranged from $58.02 to $58.6850. The reporting person will provide to the issuer, a security holder of the issuer, or the SEC staff, upon request, full information regarding the number of shares sold at each price within the range.
  • [F10]Amount includes restricted stock units acquired pursuant to a dividend equivalent reinvestment feature.
  • [F2]Amount includes shares acquired pursuant to a dividend reinvestment plan.
  • [F3]This option is 100% vested.
  • [F4]This option vests in three annual installments (33%, 33%, and 34%) beginning on the date shown.
  • [F5]These units (acquired after 12-31-04) convert into shares of common stock on a 1-for-1 basis.
  • [F6]These units (acquired after 12-31-04) convert into shares of common stock upon the earlier of certain termination events as specified in the Key Employee Deferred Compensation Plan or such earlier date as selected by the participant, subject to holding periods required by law.
  • [F7]Amount includes stock units acquired pursuant to a dividend equivalent feature.
  • [F8]These restricted stock units convert into shares of common stock on a 1-for-1 basis.
  • [F9]These restricted stock units vest in three annual installments (33%, 33%, and 34%) beginning on the date shown.

Documents

1 file
  • 4
    doc4.xmlPrimary